Changing Paradigms in the Topical Treatment of Psoriasis

April 29, 2024

FDA Accepts UCB’s sBLA for 2 mL Bimzelx Device

April 22, 2024

EC Gives Nod to Ustekinumab Biosimilar

April 22, 2024

FDA Green Lights New Stelara Biosimilar

April 16, 2024

Paragon Therapeutics’ Oruka Merges With ARCA to Advance Novel Treatments for PsO, PsA

April 3, 2024

Rodney Cotton Joins Castle Biosciences’ Board of Directors

March 28, 2024

IKBKB Genetic Mutation Implicated in PsO, PsA

March 25, 2024

GPP Vs. AGEP: Newly Developed Scoring System Helps Dermatologists Make the Differential Dx

March 21, 2024

FDA Expands Spevigo Approval to Include Teens With GPP

March 19, 2024

Actor Ted Danson, BMS Team Up for New PsO Campaign

March 19, 2024

One-year Data: Apremilast Demonstrates Sustained Improvement in Kids With PsO

March 13, 2024

Johnson & Johnson’s Oral IL-23 Receptor Blocker Shows Sustained Efficacy for Up to One Year in PsO

March 9, 2024